These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32952920)

  • 21. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1-34)] in postmenopausal osteoporosis.
    Cosman F; Eriksen EF; Recknor C; Miller PD; Guañabens N; Kasperk C; Papanastasiou P; Readie A; Rao H; Gasser JA; Bucci-Rechtweg C; Boonen S
    J Bone Miner Res; 2011 Mar; 26(3):503-11. PubMed ID: 20814967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fracture risk in children with a forearm injury is associated with volumetric bone density and cortical area (by peripheral QCT) and areal bone density (by DXA).
    Kalkwarf HJ; Laor T; Bean JA
    Osteoporos Int; 2011 Feb; 22(2):607-16. PubMed ID: 20571770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prior ankle fractures in postmenopausal women are associated with low areal bone mineral density and bone microstructure alterations.
    Biver E; Durosier C; Chevalley T; Herrmann FR; Ferrari S; Rizzoli R
    Osteoporos Int; 2015 Aug; 26(8):2147-55. PubMed ID: 25851699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous Zoledronic Acid 5 mg on Bone Turnover Markers and Bone Mineral Density in East China Subjects with Newly Diagnosed Osteoporosis: A 24-month Clinical Study.
    Liang BC; Shi ZY; Wang B; Wu P; Kong LC; Yao JL; Li CW; Shi XL
    Orthop Surg; 2017 Feb; 9(1):103-109. PubMed ID: 28276638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term changes in bone metabolism, bone mineral density, quantitative ultrasound parameters, and fracture incidence after spinal cord injury: a cross-sectional observational study in 100 paraplegic men.
    Zehnder Y; Lüthi M; Michel D; Knecht H; Perrelet R; Neto I; Kraenzlin M; Zäch G; Lippuner K
    Osteoporos Int; 2004 Mar; 15(3):180-9. PubMed ID: 14722626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Automated simulation of areal bone mineral density assessment in the distal radius from high-resolution peripheral quantitative computed tomography.
    Burghardt AJ; Kazakia GJ; Link TM; Majumdar S
    Osteoporos Int; 2009 Dec; 20(12):2017-24. PubMed ID: 19330422
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion.
    Chen F; Dai Z; Kang Y; Lv G; Keller ET; Jiang Y
    Osteoporos Int; 2016 Apr; 27(4):1469-1476. PubMed ID: 26556733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paraplegia-related alterations of bone density in forearm and hip in Greek patients after spinal cord injury.
    Vlychou M; Papadaki PJ; Zavras GM; Vasiou K; Kelekis N; Malizos KN; Fezoulidis IB
    Disabil Rehabil; 2003 Apr; 25(7):324-30. PubMed ID: 12745956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of bone biochemical markers with dual-energy x-ray absorptiometry for early determination of bone loss in persons with spinal cord injury.
    Maïmoun L; Couret I; Micallef JP; Peruchon E; Mariano-Goulart D; Rossi M; Leroux JL; Ohanna F
    Metabolism; 2002 Aug; 51(8):958-63. PubMed ID: 12145766
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pediatric Reference Ranges for Ultradistal Radius Bone Density: Results from the Bone Mineral Density in Childhood Study.
    Kindler JM; Kalkwarf HJ; Lappe JM; Gilsanz V; Oberfield S; Shepherd JA; Kelly A; Winer KK; Zemel BS
    J Clin Endocrinol Metab; 2020 Oct; 105(10):e3529-39. PubMed ID: 32561914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Administration of Intravenous Zoledronic Acid Every 3 Months vs. Annually in β-thalassemia Patients with Low Bone Mineral Density: a Retrospective Comparison of Efficacy.
    Darvishi-Khezri H; Kosaryan M; Akbarzadeh R; Aliasgharian A; Fazli M
    Med Arch; 2018 Jun; 72(3):170-173. PubMed ID: 30061760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial.
    Reid DM; Devogelaer JP; Saag K; Roux C; Lau CS; Reginster JY; Papanastasiou P; Ferreira A; Hartl F; Fashola T; Mesenbrink P; Sambrook PN;
    Lancet; 2009 Apr; 373(9671):1253-63. PubMed ID: 19362675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.
    Black DM; Delmas PD; Eastell R; Reid IR; Boonen S; Cauley JA; Cosman F; Lakatos P; Leung PC; Man Z; Mautalen C; Mesenbrink P; Hu H; Caminis J; Tong K; Rosario-Jansen T; Krasnow J; Hue TF; Sellmeyer D; Eriksen EF; Cummings SR;
    N Engl J Med; 2007 May; 356(18):1809-22. PubMed ID: 17476007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of zoledronic acid on bone mineral density around prostheses and bone metabolism markers after primary total hip arthroplasty in females with postmenopausal osteoporosis.
    Zhou W; Liu Y; Guo X; Yang H; Xu Y; Geng D
    Osteoporos Int; 2019 Aug; 30(8):1581-1589. PubMed ID: 31115592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trabecular bone microarchitecture is deteriorated in men with spinal cord injury.
    Modlesky CM; Majumdar S; Narasimhan A; Dudley GA
    J Bone Miner Res; 2004 Jan; 19(1):48-55. PubMed ID: 14753736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual-energy X-ray absorptiometry overestimates bone mineral density of the lumbar spine in persons with spinal cord injury.
    Bauman WA; Schwartz E; Song IS; Kirshblum S; Cirnigliaro C; Morrison N; Spungen AM
    Spinal Cord; 2009 Aug; 47(8):628-33. PubMed ID: 19153590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Periostin and sclerostin levels in individuals with spinal cord injury and their relationship with bone mass, bone turnover, fracture and osteoporosis status.
    Maïmoun L; Ben Bouallègue F; Gelis A; Aouinti S; Mura T; Philibert P; Souberbielle JC; Piketty M; Garnero P; Mariano-Goulart D; Fattal C
    Bone; 2019 Oct; 127():612-619. PubMed ID: 31351195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal changes in bone mineral density and trabecular bone score following yearly zoledronic acid infusion in postmenopausal osteoporosis-a retrospective-prospective study from southern India.
    Sooragonda B; Cherian KE; Jebasingh FK; Dasgupta R; Asha HS; Kapoor N; Thomas N; Paul TV
    Arch Osteoporos; 2019 Jul; 14(1):79. PubMed ID: 31321603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of zoledronic acid on bone mineral density in patients undergoing androgen deprivation therapy.
    Israeli RS; Rosenberg SJ; Saltzstein DR; Gottesman JE; Goldstein HR; Hull GW; Tran DN; Warsi GM; Lacerna LV
    Clin Genitourin Cancer; 2007 Mar; 5(4):271-7. PubMed ID: 17553207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole-body vibration may not affect bone mineral density and bone turnover in persons with chronic spinal cord injury: A preliminary study.
    Maïmoun L; Gelis A; Serrand C; Mura T; Brabant S; Garnero P; Mariano-Goulart D; Fattal C
    J Spinal Cord Med; 2023 Nov; ():1-13. PubMed ID: 37930641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.